Clinical Pharmacokinetics

Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins
pp. 331-347(17)
Authors: Mahmood, Iftekhar; Green, Martin D.

Role of Cytochrome P450 Activity in the Fate of Anticancer Agents and in Drug Resistance: Focus on Tamoxifen, Paclitaxel and Imatinib Metabolism
pp. 349-366(18)
Author: Rochat, Bertrand

Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations: The Past, the Present and Recommendations for the Future
pp. 367-393(27)
Authors: Avramis, Vassilios I.; Panosyan, Eduard H.

Pharmacokinetics of Famotidine in Infants
pp. 395-406(12)
Authors: Wenning, Larissa A.; Murphy, M. Gail; James, Laura P.; Blumer, Jeffrey L.; Marshall, James D.; Baier, John; Scheimann, Ann O.; Panebianco, Deborah L.; Zhong, Ling; Eisenhandler, Roy; Yeh, Kuang C.; Kearns, Gregory L.

Topiramate Pharmacokinetics in Children and Adults with Epilepsy: A Case-Matched Comparison Based on Therapeutic Drug Monitoring Data
pp. 407-416(10)
Authors: Battino, Dina; Croci, Danilo; Rossini, Alessandro; Messina, Sara; Mamoli, Daniela; Perucca, Emilio

Pharmacokinetic/Pharmacodynamic and Time-to-Event Models of Ribavirin-Induced Anaemia in Chronic Hepatitis C
pp. 417-428(12)
Authors: Tod, Michel; Farcy-Afif, Muriel; Stocco, Jeanick; Boyer, Nathalie; Bouton, Valérie; Sinègre, Martine; Marcellin, Patrick

Absence of Pharmacokinetic Interactions of the Combined Contraceptive Vaginal Ring NuvaRing^® with Oral Amoxicillin or Doxycycline in Two Randomised Trials
pp. 429-438(10)
Authors: Dogterom, Peter; Michiel W. van den Heuvel,; Thomsen, Torben

Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs
pp. 439-440(2)
Author: Adis International Limited,

The Authors’ Reply
pp. 439-440(2)
Author: Adis International Limited,